Loading...
Este registro ha sido borrado. Debido a que está vinculado a un registro publicado, está disponible aquí solo como una referencia.
Haga clic aquí para ver el registro borradoEste registro ha sido actualizado. Esta no es la última versión publicada. Haga clic aquí para ver la última versión del registro
Organismos vivos modificados
(LMO)
En la imagen que se encuentra abajo se identifica el OVM mediante su identificador único, nombre comercial y enlace a esta página del CIISB. Haga clic en el enlace para descargar una imagen más grande en su computadora. Para obtener ayuda sobre cómo utilizarlo, vaya a las páginas de enlace rápido al OVM.
VECTORMUNE® FP-LT + AE Vaccine
EN
FP/LT
No
-
Persona:Dr Alexis Henry Gaetan GouxPresident of CIBio,Rua Manuel Joaquim Filho, 303 Pulínia - SPPaulínia, São Paulo
13140-000, BrasilTeléfono: 551938337700,Fax: 55193833-7722,Correo electrónico: alexisgoux@ceva.com,Sitio web: http://www.ceva.com.br/,Organización relacionadaCeva Saúde Animal Ltda (CEVA)Rua Manuel Joaquim Filho, 303 Pulínia - SPPaulínia, São Paulo
13140-000, BrasilTeléfono: 551938337700,Fax: 55193833-7722,Correo electrónico: alexisgoux@ceva.com,Sitio web: http://www.ceva.com.br/,
VECTORMUNE FP-LT + AE is a genetically engineered, live fowlpox virus vaccine for use in chickens. The fowlpox virus has been genetically modified to express key protective laryngotracheitis (LT) virus antigens. In addition to the fowlpox virus vector, this freeze-dried vaccine contains a conventional live avian encephalomyelitis (AE) virus for use as an aid in the prevention of avian encephalomyelitis.
EN
El término "organismo receptor" hace referencia a un organismo (modificado o no modificado) que fue objeto de una modificación genética, en tanto que "organismos parentales" hace referencia a los implicados en el cruzamiento o la fusión de células.
-
BCH-ORGA-SCBD-105171-4 Organismo Fowlpox virus (FOWPV)Virus
ES
-
VECTORMUNE® FP-LT Vaccine| Ceva Saúde Animal Ltda(CEVA) | Producción de compuestos médicos o farmacéuticos (humanos o animales) (Vacunas)
pUC18
EN
- Otros (Homologous Recombination)
Algunos de estos elementos genéticos pueden estar presentes como fragmentos o formas truncadas. Por favor, véanse las notas a continuación, en los casos en los que corresponda.
-
BCH-GENE-SCBD-105174-2 Glycoprotein B gene | Gallid alphaherpesvirus 1 (ILTV)Secuencia de codificación de proteínas | Producción de compuestos médicos o farmacéuticos (humanos o animales) (Vacunas)
-
BCH-GENE-SCBD-105173-2 UL32 gene | Gallid alphaherpesvirus 1 (ILTV)Secuencia de codificación de proteínas | Producción de compuestos médicos o farmacéuticos (humanos o animales) (Vacunas)
Two genes originating from ILTV, namely UL32 and gB, were introduced into a FPV vector. The genes were ligated into a pUC18 transformation vector in addition to a lacZ marker gene from E. coli, using two synthetic promoters and an FPV homologous recombination site.
The vector was constructed by cloning a 3 kb fragment of FPV genomic DNA into the pUC18 vector. An internal fragment of 175bp was removed and replaced by a construct containing the UL32 coding sequenece with a synthetic PS promoter, followed by a lacZ gene directed by the synthetic promoter P17. This was followed by the coding sequence of the gB gene which was also directed by the synthetic promoter PS.
The synthetic promoters PS and P17 emulate the consensus early/late promoter and the early poxvirus promoter, respectively. Genes gB and UL32 code for the ILTV antigens, while the gene lacZ operates as a reporter gene to facilitate recombinant virus selection.
This construct and the the parental FPV strain were co-transformed into chicken embryo fibroblasts and incubated under conditions that favour homologous recombination.
Homologous recombination and integration of the genetic construct was confirmed by Southern blot using probes that hybridized in both sides of the insertion site. DNA sequencing was also conducted. Expression of genes UL32 and gB was confirmed by Western blot.
EN
The vector was constructed by cloning a 3 kb fragment of FPV genomic DNA into the pUC18 vector. An internal fragment of 175bp was removed and replaced by a construct containing the UL32 coding sequenece with a synthetic PS promoter, followed by a lacZ gene directed by the synthetic promoter P17. This was followed by the coding sequence of the gB gene which was also directed by the synthetic promoter PS.
The synthetic promoters PS and P17 emulate the consensus early/late promoter and the early poxvirus promoter, respectively. Genes gB and UL32 code for the ILTV antigens, while the gene lacZ operates as a reporter gene to facilitate recombinant virus selection.
This construct and the the parental FPV strain were co-transformed into chicken embryo fibroblasts and incubated under conditions that favour homologous recombination.
Homologous recombination and integration of the genetic construct was confirmed by Southern blot using probes that hybridized in both sides of the insertion site. DNA sequencing was also conducted. Expression of genes UL32 and gB was confirmed by Western blot.
ES
- Vacuna
ES
ES
- Vectormune® FP-LT+AE - Biomune Company [ English ]
- Vectormune® FP-LT+AE - CTNBio [ English ]
Loading...